NewAmsterdam Pharma stockNAMS
NewAmsterdam Pharma trades at $18.89, 55.2% below its 52-week high (May 11, 2026). The price is below its 50- and 200-day averages, a downtrend. −46.2% year to date, −50.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 3, 2027.
Ratings, candles, signals and the screener for NAMS — after you log in
Open the terminalFrequently asked questions about NewAmsterdam Pharma
What is the NewAmsterdam Pharma stock price?
At the close on Nov 5, 2026: $18.89 (−9.75% on the day). 52-week high: $42.20 on May 11, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does NewAmsterdam Pharma report earnings?
The next quarterly report is on Mar 3, 2027. Last quarter, earnings per share changed +70% year over year, revenue +5,407%.
Does NewAmsterdam Pharma pay dividends?
No, NewAmsterdam Pharma does not pay dividends.
Where does NewAmsterdam Pharma trade and how to buy it?
Ticker NAMS, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy NewAmsterdam Pharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for NAMS are in the terminal after you log in.